Securities and Exchange Commission v. Lemelson

CourtDistrict Court, D. Massachusetts
DecidedMarch 30, 2022
Docket1:18-cv-11926
StatusUnknown

This text of Securities and Exchange Commission v. Lemelson (Securities and Exchange Commission v. Lemelson) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Securities and Exchange Commission v. Lemelson, (D. Mass. 2022).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ___________________________________ ) SECURITIES AND EXCHANGE COMMISSION,) ) Plaintiff, ) ) Civil Action v. ) No. 18-11926-PBS ) GREGORY LEMELSON and LEMELSON ) CAPITAL MANAGEMENT, LLC, ) ) Defendants, ) ) and ) ) THE AMVONA FUND, LP, ) ) Relief Defendant. ) ______________________________ )

MEMORANDUM AND ORDER March 30, 2022 Saris, D.J. INTRODUCTION The Securities and Exchange Commission (“SEC”) brought a civil enforcement action against Defendants Gregory Lemelson (“Lemelson”) and Lemelson Capital Management, LP (“LCM”) for violations of the Securities Exchange Act and the Investment Advisers Act of 1940 (the “Advisers Act”). Following a trial, the jury returned a mixed verdict on November 5, 2021, finding Lemelson liable for three false statements and not liable under a scheme liability theory and the Advisers Act. The SEC now moves for entry of final judgment (Dkt. 244). The SEC requests this Court order: (1) an injunction permanently restraining and enjoining Defendants from violating Section 10(b) of the Securities Exchange Act [15 U.S.C. § 78j(b)] and Rule 10b-5 [17 C.F.R. § 240.10b-5]; (2) a $656,500 civil penalty against Lemelson; (3) a $775,000 civil penalty against LCM; (4) $656,500

in joint and several disgorgement against Lemelson and LCM; and (5) prejudgment interest of $208,624. Lemelson opposes all five components of the proposed order (Dkt. 260). After hearing, the Court enters the following final judgment: Defendants are enjoined from violating Section 10(b) of the Exchange Act and Rule 10b-5 for a period of five years, and Lemelson is ordered to pay a Tier III civil penalty in the amount of $160,000. FACTUAL BACKGROUND

I. The Charged Conduct Lemelson served as Chief Investment Officer of LCM in 2014. Lemelson managed the Amvona Fund through LCM, and he “made all investment decisions for that fund.” Dkt. 246-5 (Parties’ Agreed-to Facts), ¶ 5. Beginning in May 2014, the Amvona Fund took a short position in shares of Ligand Pharmaceuticals, Inc. Lemelson and LCM took a short position on behalf of the Amvona Fund on thirteen dates between May 2014 and October 2014. The total short position from this period was $5,082,334.60. Between June and August of that year, Lemelson published five reports concerning Ligand. In a report published July 3, 2014, Lemelson represented that Viking Therapeutics, Inc., (“Viking”), a company that signed a licensing deal with Ligand, “does not intend to conduct any preclinical studies or trials and does not own any products or intellectual property or manufacturing abilities and leases space from Ligand.” Dkt. 246-11 at 7.

Lemelson wrote that “Viking appears to be a single-purpose vehicle created to raise more capital from public markets for its sponsor, Ligand Pharmaceuticals.” Id. In the same report, Lemelson mused that Viking had a “curious relationship” with its accounting firm and stated that Viking “has not yet even consulted with the firm on any materials issues” and “[t]he financial statements provided on the S1 accordingly are unaudited.” Id. at 9–10.

Between June and October, Lemelson also gave four interviews on Benzinga Premarket Prep Shows (“Benzinga”). During his interview with Benzinga on June 19, 2014, Lemelson described a phone call with Bruce Voss, Ligand’s investor relations firm representative. Lemelson said “It’s literally going to go away, I mean, I had discussions with [Ligand] management just yesterday – excuse me, their [Ligand’s] IR [investor relations] firm. And they basically agreed. They said, ‘Look, we understand Promacta’s going away.’” Dkt. 246-5, ¶ 14. Lemelson and LCM covered the short position on five dates, for a total of $3,785,690.19. The Amvona Fund profited $1,296,644.41 from the short position in Ligand.

II. The Litigation The SEC charged Lemelson and LCM with violations of Section 10(b) and Rule 10b-5 of the Securities Exchange Act and Section 206(4) and Rule 206(4)-8 of the Investment Advisers Act. The jury determined that the SEC proved Lemelson “intentionally or recklessly made untrue statements of a material fact or omitted to state a material fact necessary in order to make the statements made, in light of the circumstances under which they

were made, not misleading” as to the Benzinga interview, the Viking audit statement, and the Viking preclinical trial statement. Dkt. 246-8 (Verdict Form) at 1-2. The jury answered “No” for the allegedly false statements about Ligand’s insolvency and found no Rule 10b-5 scheme liability. The jury also answered “No” on the two questions related to whether the SEC proved that Lemelson intentionally, recklessly, or negligently violated the Advisers Act. Id.

Over the course of this acrimonious litigation, this Court has issued opinions on a motion to dismiss (Dkt. 29), motions for summary and partial summary judgment (Dkt. 146), a motion in limine to exclude argument that the statements were opinions (Dkt. 204), and a motion for renewed judgment as a matter of law (Dkt. 243), and the Court assumes familiarity with those opinions.

DISCUSSION I. Injunction A. Legal Standard Section 21(d) of the Exchange Act provides that the SEC may bring an action to enjoin a person “engaged or [] about to engage” in violations of the Act, and “upon a proper showing a permanent or temporary injunction or restraining order shall be granted without bond.” 15 U.S.C. § 78u(d)(1). An injunction is appropriate where there is, “at a minimum, proof that a person is engaged in or is about to engage in a substantive violation of either one of the Acts or of the regulations promulgated thereunder.” SEC v. Sargent, 329 F.3d 34, 39 (1st Cir. 2003)

(quoting Aaron v. SEC, 446 U.S. 680, 700–01 (1980)). The legal standard for issuing an injunction is “reasonable likelihood of recidivism, not an imminent threat of it.” Sargent, 329 F.3d at 39. Courts assess the likelihood of recidivism through several, non-dispositive factors: “the nature of the violation, including its egregiousness and its isolated or repeated nature”; “whether the defendants will, owing to their occupation, be in a position to violate again”; and “whether the defendants have recognized the wrongfulness of their conduct.” Id. The Second Circuit has cautioned that “when defendants are active in the securities field ‘[a]n injunction is a drastic remedy, not a mild prophylactic.’” SEC v. Am. Bd. of Trade, Inc., 751 F.2d 529, 535-36 (2d Cir. 1984) (quoting Aaron, 446 U.S. at 703 (Burger, C.J., concurring)); see also SEC v. Johnson, 595 F.Supp.2d 40, 45 (D.D.C. 2009) (imposing a

temporary injunction of five years and warning of the seriousness of a permanent injunction). One court has held that violations of securities laws are not enough on their own to satisfy egregiousness. See SEC v. Snyder, No. H-03-04658, 2006 WL 6508273, at *2 (S.D. Tex. Aug. 22, 2006). Many district courts in this circuit have issued permanent

injunctions for egregious conduct occurring over prolonged periods of time. For prolonged schemes, see SEC v. Wall, No. 2:19-cv-00139-JHR, 2020 WL 1539919, at *8 (D. Me. Mar. 31, 2020); SEC v. Chan, 465 F. Supp. 3d 18, 38 (D. Mass. 2020); SEC v. Present, No. 14-cv-14692-LTS, 2018 WL 1701972 at *1 (D. Mass. Mar. 20, 2018). For repeated conduct, see SEC v. Weed, 315 F. Supp. 3d 667, 676 (D. Mass.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Root v. Railway Co.
105 U.S. 189 (Supreme Court, 1882)
Aaron v. Securities & Exchange Commission
446 U.S. 680 (Supreme Court, 1980)
Securities & Exchange Commission v. Sargent
329 F.3d 34 (First Circuit, 2003)
Securities & Exchange Commission v. Razmilovic
738 F.3d 14 (Second Circuit, 2013)
Securities & Exchange Commission v. Druffner
517 F. Supp. 2d 502 (D. Massachusetts, 2007)
Securities & Exchange Commission v. Johnson
595 F. Supp. 2d 40 (District of Columbia, 2009)
Securities & Exchange Commission v. Teo
746 F.3d 90 (Third Circuit, 2014)
Securities and Exchange Commission v. Joseph J. Monterosso
557 F. App'x 917 (Eleventh Circuit, 2014)
Liu v. SEC. & Exch. Comm'n
591 U.S. 71 (Supreme Court, 2020)
Securities & Exchange Commission v. Tropikgadget FZE.
146 F. Supp. 3d 270 (D. Massachusetts, 2015)
Sec. & Exch. Comm'n v. Weed
315 F. Supp. 3d 667 (District of Columbia, 2018)
Securities & Exchange Commission v. Kern
425 F.3d 143 (Second Circuit, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Securities and Exchange Commission v. Lemelson, Counsel Stack Legal Research, https://law.counselstack.com/opinion/securities-and-exchange-commission-v-lemelson-mad-2022.